1. Detection of drug‐responsive B lymphocytes and antidrug IgG in patients with β‐lactam hypersensitivity. Issue 6 (8th December 2016) Authors: Amali, M. O.; Sullivan, A.; Jenkins, R. E.; Farrell, J.; Meng, X.; Faulkner, L.; Whitaker, P.; Peckham, D.; Park, B. K.; Naisbitt, D. J. Journal: Allergy Issue: Volume 72:Issue 6(2017:Jun.) Page Start: 896 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. HLA‐DQ allele‐restricted activation of nitroso sulfamethoxazole‐specific CD4‐positive T lymphocytes from patients with cystic fibrosis. Issue 8 (August 2015) Authors: Ogese, M. O.; Saide, K.; Faulkner, L.; Whitaker, P.; Peckham, D.; Alfirevic, A.; Baker, D. M.; Sette, A.; Pirmohamed, M.; Park, B. K.; Naisbitt, D. J. Journal: Clinical & experimental allergy Issue: Volume 45:Issue 8(2015:Aug.) Page Start: 1305 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PB1998: WEEKLY OPPOSED TO BI-WEEKLY BORTEZOMIB AS PART OF INDUCTION CHEMOTHERAPY IN NEWLY DIAGNOSED MULTIPLE MYELOMA IS BETTER TOLERATED AND EQUALLY EFFICIENT: REAL-WORLD DATA FROM A RETROSPECTIVE AUDIT. (23rd June 2022) Authors: Faulkner, L.; Garg, M.; Suresh, C. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1869 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗